Latest News
Krystal Biotech, Inc.
- Krystal Biotech, Inc. Estimates – MUN:4KB
- Krystal Biotech to Report Third Quarter 2026 Financial Results on November 2, 2026
- Krystal Biotech Reports Over 80% Lesion Reduction in Rare Skin Cancer Trial
- Krystal’s KB113 shrinks injected and untreated skin tumors in three-patient Gorlin study
- Krystal Biotech announces positive results for KB113 in Gorlin syndrome: Can KRYS recover above the MA-20?
- Krystal Biotech reports positive early data for Gorlin syndrome trial
- Krystal Biotech Announces Positive Clinical Data for New Dermatology Program KB113 Demonstrating Broad Basal Cell Carcinoma Regression in Patients with Gorlin Syndrome
- Krystal Biotech: Vyjuvek's Success Is Becoming Its Growth Problem (Downgrade)
- Krystal Biotech: My Analysis Suggests Stock Has Not Yet Reached Peak Value (NASDAQ:KRYS)
- Krystal Biotech rated 'Buy' on strong Vyjuvek s...
- $1000 Invested In Krystal Biotech 5 Years Ago Would Be Worth This Much Today
- Krystal Biotech stock initiated at buy by Goldman Sachs
Headlines from the last 30 days, linking to the original publishers. See all market news →